Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2003-5-14
pubmed:abstractText
Various dermatologic manifestations are observed in the different lupus subsets. Lupus lesions are characterized by a dermo-epidermal dermatitis. Other lesions, vascular or non vascular, are essentially present in association with systemic lupus erythematosus. Acute, subacute and chronic lupus erythematosus are distinguishable according to their clinical aspects, pathological features and evolution. Acute lesions are either localized to the midface or widespread. Subacute lesions may be annular or psoriasiform. Chronic lupus erythematosus includes localized or widespread discoid lupus, lupus tumidus, chilblain lupus and panniculitis. Therapy of cutaneous lupus is mainly based on antimalarials and avoidance of sun irradiation. In refractory cutaneous lupus, no universal guidelines are currently available. Except for acrosyndromes and urticaria-like lesions, vascular lesions may be due to vasculitis or thrombosis. An accurate diagnosis is absolutely necessary since therapy is different in thrombosis and vasculitis. Non vascular and non lupus lesions are numerous, some of them require special treatment such as dapsone for bullous lupus.
pubmed:language
fre
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Acitretin, http://linkedlifedata.com/resource/pubmed/chemical/Adrenal Cortex Hormones, http://linkedlifedata.com/resource/pubmed/chemical/Antimalarials, http://linkedlifedata.com/resource/pubmed/chemical/Dapsone, http://linkedlifedata.com/resource/pubmed/chemical/Dermatologic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations, http://linkedlifedata.com/resource/pubmed/chemical/Glucosamine, http://linkedlifedata.com/resource/pubmed/chemical/Hydroxychloroquine, http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents, http://linkedlifedata.com/resource/pubmed/chemical/Isotretinoin, http://linkedlifedata.com/resource/pubmed/chemical/Keratolytic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Salazopyrine, http://linkedlifedata.com/resource/pubmed/chemical/Sulfasalazine, http://linkedlifedata.com/resource/pubmed/chemical/Thalidomide
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0003-410X
pubmed:author
pubmed:issnType
Print
pubmed:volume
154
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
33-44
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:12746657-Acitretin, pubmed-meshheading:12746657-Adrenal Cortex Hormones, pubmed-meshheading:12746657-Adult, pubmed-meshheading:12746657-Antimalarials, pubmed-meshheading:12746657-Clinical Trials as Topic, pubmed-meshheading:12746657-Dapsone, pubmed-meshheading:12746657-Dermatologic Agents, pubmed-meshheading:12746657-Diagnosis, Differential, pubmed-meshheading:12746657-Drug Combinations, pubmed-meshheading:12746657-Female, pubmed-meshheading:12746657-Glucosamine, pubmed-meshheading:12746657-Humans, pubmed-meshheading:12746657-Hydroxychloroquine, pubmed-meshheading:12746657-Immunosuppressive Agents, pubmed-meshheading:12746657-Infant, Newborn, pubmed-meshheading:12746657-Isotretinoin, pubmed-meshheading:12746657-Keratolytic Agents, pubmed-meshheading:12746657-Lupus Erythematosus, Cutaneous, pubmed-meshheading:12746657-Lupus Erythematosus, Discoid, pubmed-meshheading:12746657-Male, pubmed-meshheading:12746657-Middle Aged, pubmed-meshheading:12746657-Skin, pubmed-meshheading:12746657-Sulfasalazine, pubmed-meshheading:12746657-Thalidomide, pubmed-meshheading:12746657-Thrombosis, pubmed-meshheading:12746657-Ultraviolet Therapy, pubmed-meshheading:12746657-Vasculitis
pubmed:year
2003
pubmed:articleTitle
[Classification of dermatologic manifestations in lupus erythematosus].
pubmed:affiliation
Service de Médecine Interne, Hôpital de la Pitié, 83, boulevard de l'Hôpital, 75651 Paris Cedex 13. camille.frances@psl.ap-hop-paris.fr
pubmed:publicationType
Journal Article, English Abstract